Professor Che Connon
Co-founder
Che is the scientific founder at Atelerix, and is passionate about cell biology and regenerative medicine.
Board
Clive Stanway
Clive trained as a scientist in cell and molecular biology at Imperial College and Oxford University, rising to junior faculty status.
Andrew Muir
Andrew is a Director at the venture capital firm, Midven. As Fund Principal of the UK Innovation & Science Seed Fund and the Early Advantage Fund, Andrew led two rounds of investment into Atelerix
Dr Mick McLean
Director and Co-Founder
Mick is a chemist by training, a biologist by inclination and a business leader by experience.
Management Team
Dr Edwin Wagena
Chief Executive Officer
Ed is an experienced hands-on senior executive, trained as epidemiologist with a PhD in Medicine, with more than 20 years of experience in drug development.
Dr Steve Swioklo
Chief Scientific Officer
Steve is a co-founder of Atelerix and Chief Scientific Officer for the company, with a deep interest in the development of new technologies for biomedical applications.